Passion for Innovation. Compassion for Patients.
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.
For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com.
Please see below for global employment opportunities:
Daiichi Sankyo Europe: http://linkd.in/1C7vu7Z
Daiichi Sankyo Inc: http://linkd.in/1aDztT4
Daiichi Sankyo Spain: http://linkd.in/1DUavKt
Daiichi Sankyo Germany: http://linkd.in/1GZA11G
Daiichi Sankyo UK: http://linkd.in/1FwcGTo
Daiichi Sankyo Switzerland: http://linkd.in/1GZA3GR
Daiichi Sankyo France: http://linkd.in/1yPOAhu
Daiichi Sankyo Brazil: http://linkd.in/1CMnnQO
Daiichi Sankyo Ireland: http://linkd.in/1GZAbX2
Research & Development, Manufacturing, and Sales & Marketing of Pharmaceutical Products
Daiichi Sankyo
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
La Mut' - GHM de Grenoble healthtech, Hospitals and Health Care | Other 27 Oct 2024 | | ||
FIRALIS S.A. biotech, deeptech, healthtech, Biotechnology Research | Other 14 Oct 2024 | | ||
Priothera SAS biotech, deeptech, healthtech | Other 8 Oct 2024 | | ||
CHU Grenoble Alpes healthtech, Hospitals and Health Care | Other 7 Oct 2024 | | ||
IUCT-Oncopole healthtech, Hospitals and Health Care | Other 1 Oct 2024 | | ||
Cancer Contribution biotech, deeptech, healthtech, Civic and Social Organizations | Other 2 Oct 2024 | | ||
Clinique La Croix du Sud healthtech | Other 2 Nov 2024 | | ||
Clinique Belharra healthtech | Other 25 Oct 2024 | | ||
Healthcare Businesswomen’s Association healthtech, Non-profit Organizations | Other 26 Sep 2024 | | ||
H1 healthtech, Software Development | Other 6 Sep 2024 | |